STOCK TITAN

PTC Therapeutics to Participate at 41st Annual J.P. Morgan Healthcare Conference

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

PTC Therapeutics, based in South Plainfield, N.J., will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023, at 7:30 a.m. PST/10:30 a.m. EST.

The presentation can be accessed via a live webcast on the company’s Investor section and will be archived for 30 days. PTC focuses on developing medicines for rare disorders, aiming to provide access to transformative treatments for patients with unmet medical needs.

Loading...
Loading translation...
Argus Session date unavailable
-0.20% session move Open Argus
Details

News Market Reaction – PTCT

The recorded move for PTCT in the trading session of this news was -0.20%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SOUTH PLAINFIELD, N.J., Jan. 4, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on Monday, Jan. 9, at 7:30 a.m. PST/10:30 a.m. EST.

The presentation will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection. 

About PTC Therapeutics, Inc.

PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Instagram, Facebook, Twitter, and LinkedIn.

For More Information:

Investors:
Kylie O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-41st-annual-jp-morgan-healthcare-conference-301713827.html

SOURCE PTC Therapeutics, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is PTC Therapeutics presenting at the J.P. Morgan Healthcare Conference?

PTC Therapeutics will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023.

When and where will PTC's presentation take place?

The presentation will occur on January 9, 2023, at 7:30 a.m. PST (10:30 a.m. EST) in San Francisco.

How can I watch PTC Therapeutics' presentation?

You can watch PTC Therapeutics' presentation via a live webcast on their Investor section at www.ptcbio.com.

Will the PTC Therapeutics presentation be available later?

Yes, the presentation will be archived for 30 days following the live event.

What is the focus of PTC Therapeutics as a company?

PTC Therapeutics is dedicated to developing and commercializing medicines for patients with rare disorders.

Keep reading